04893nam 2201213z- 450 991058021270332120231214133528.0(CKB)5690000000011961(oapen)https://directory.doabooks.org/handle/20.500.12854/87484(EXLCZ)99569000000001196120202207d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierHospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic TherapyBaselMDPI - Multidisciplinary Digital Publishing Institute20221 electronic resource (206 p.)3-0365-4418-6 3-0365-4417-8 Bacterial resistance to known and currently used antibiotics represents a growing issue worldwide. It poses a major problem in the treatment of infectious diseases in general and hospital-acquired infections in particular. This is in part due to the overuse and misuse of antibiotics in past decades, which led to the selection of highly resistant bacteria and even so-called superbugs – multidrug-resistant (MDR) bacteria. Nosocomial infections, particularly, are often caused by MDR bacterial pathogens and the treatment of such infections is very complicated and extensive, often leading to various side effects, including adverse effects on the natural human microbiome. At the same time, the development of novel antibiotics is lagging with very few new ones in the pipeline. Finding viable alternatives to treat such infections may help to overcome these therapeutic issues. This publication brings novel developments in the field of bacterial resistance, mainly in the hospital settings, adequate antibiotic therapy, and identification of compounds useful to battle this growing issue.Hospital Acquired Infections, Multidrug Resistant MedicinebicsscEpidemiology & medical statisticsbicsscVREGIThemato-oncological patientsclonalityantibiotic stewardshipresistanceconsumption of antibioticsclonal spreadEnterococcus faeciumEnterococcus faecalislinezolid resistance23S rRNAoptrAcarbapenem-resistant Klebsiella pneumoniaecarbapenem-resistant Acinetobacter baumanniiN-acetylcysteineseptic shockcritically ill patientsnewborninfectionbacteriaantibiotic therapyhopsC. difficilerat modelStaphylococcus aureusMRSAspa typingMLSTSCCmec typingclonal analysisepidemiologycancer patientsduration of treatmentcolistinpropensity score analysismultidrug-resistant Acinetobacter baumanniiurinary tract infectionsUTIsMDREscherichia coliKlebsiellauropathogensAMRantibiotic resistanceESBL-producing Klebsiella pneumoniaeurinary tract infectionclinical impacteconomic impactventilator-associated pneumoniaKlebsiella spp.Escherichia spp.pulsed-field gel electrophoresis (PFGE)endogenous infectionmethicillin-resistantporcine modelmethicillin-resistant Staphylococcus aureus (MRSA)long term care facilities (LTCF)multidrug resistance (MDR)enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC-PCR)ESBLPCRprimerantimicrobial resistanceinfection prevention and controlantimicrobial stewardshiphospitalcluster analysisprincipal component analysisMedicineEpidemiology & medical statisticsBostik Paveledt1304524Kolar MilanedtBostik PavelothKolar MilanothBOOK9910580212703321Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy3027524UNINA